Home›Stock Screener›Anuh Pharma›Intrinsic Value

Anuh Pharma Intrinsic Value

Anuh Pharma intrinsic value. Anuh Pharma (ANUHPHR) median intrinsic value is ₹96.80 from 10 valuation models (range ₹28–₹168), vs current price ₹84.15 — +15.0% upside (Trading Below Median Value), margin of safety 13.1%. For current market price and key ratios, visit ANUHPHR share price.

Market Price (CMP)
₹84.15
Primary Intrinsic Value
₹96.80
Market Cap
₹420.8 Cr
+15.0% Upside
Median Value
₹96.80
Value Range
₹28 - ₹168
Assessment
Trading Below Median Value
Safety Margin
13.1%

ANUHPHR Valuation Methods Summary — DCF, Graham Number & P/E

Anuh Pharma intrinsic value across 10 models vs current price ₹84.15 — upside/downside and value range per method. Compare with ANUHPHR fair price to assess whether the stock is under or overvalued.

Method Type Intrinsic Value Range Upside/Downside Details
P/E Based Valuation earnings ₹96.80 ₹77.44 - ₹116.16 +15.0% EPS: ₹4.40, Sector P/E: 22x
Book Value Method asset ₹140.80 ₹126.72 - ₹154.88 +67.3% Book Value/Share: ₹70.40, P/B: 2.0x
Revenue Multiple Method revenue ₹168.30 ₹151.47 - ₹185.13 +100.0% Revenue/Share: ₹156.80, P/S: 2.0x
EBITDA Multiple Method earnings ₹144.00 ₹129.60 - ₹158.40 +71.1% EBITDA: ₹72.00Cr, EV/EBITDA: 10x
Simple DCF (5Y) dcf ₹78.54 ₹62.83 - ₹94.25 -6.7% CF Growth: 8.5%, Discount: 15%
PEG Ratio Method growth ₹28.16 ₹25.34 - ₹30.98 -66.5% EPS Growth: 8.0%, Fair P/E: 6.4x
Growth Adjusted P/E growth ₹69.33 ₹62.40 - ₹76.26 -17.6% Revenue Growth: 10.1%, Adj P/E: 15.8x
ROE Based Valuation profitability ₹105.60 ₹95.04 - ₹116.16 +25.5% ROE: 12.5%, P/E Multiple: 12x
Graham Defensive Method conservative ₹83.48 ₹75.13 - ₹91.83 -0.8% EPS: ₹4.40, BVPS: ₹70.40
Dividend Yield Method dividend ₹60.00 ₹54.00 - ₹66.00 -28.7% DPS: ₹1.50, Target Yield: 2.5%
Method Types: Earnings Asset DCF Growth Dividend Conservative

ANUHPHR Intrinsic Value vs Market Price — All Valuation Models

Anuh Pharma fair value range ₹28–₹168 vs current market price ₹84.15 across 10 valuation models. Read ANUHPHR dividend yield for the complete payout history and dividend yield track record.

ANUHPHR Intrinsic Value Analysis — Undervalued or Overvalued?

Anuh Pharma median intrinsic value ₹96.80, current price ₹84.15 — Trading Below Median Value by 15.0%, margin of safety 13.1%.

What is the intrinsic value of ANUHPHR?

Based on our comprehensive analysis using 10 different valuation methods, the estimated intrinsic value of Anuh Pharma (ANUHPHR) is ₹96.80 (median value). With the current market price of ₹84.15, this represents a +15.0% variance from our estimated fair value.

The valuation range spans from ₹28.16 to ₹168.30, indicating ₹28.16 - ₹168.30.

Is ANUHPHR undervalued or overvalued?

Based on our multi-method analysis, Anuh Pharma (ANUHPHR) appears to be trading below median value by approximately 15.0%.

ANUHPHR Financial Health — Key Ratios vs Industry Benchmarks

Anuh Pharma financial ratios — ROE, debt-to-equity, profit margins and liquidity vs industry benchmarks and their impact on intrinsic value.

Financial Metric Current Value Industry Benchmark Assessment Impact on Valuation
Current Ratio 225.50 Industry Standard: 2.0+ Above 2.0 Measures short-term liquidity capacity
Return on Equity 12.5% Industry Standard: 15%+ Above 10% Measures shareholder return efficiency
Operating Margin 9.0% Industry Standard: 20%+ Below 10% Indicates operational efficiency level
Asset Turnover Ratio 1.41x Industry Standard: 1.0x+ Above 1.0x Measures asset utilization efficiency

ANUHPHR Cash Flow Quality — Operating & Free Cash Flow

Anuh Pharma operating cash flow, free cash flow, quality rating and sustainability score by period — key inputs to DCF intrinsic value calculation.

Period Operating Cash Flow Free Cash Flow Cash Flow Quality Sustainability Score
March 2026 ₹-3 Cr ₹-3 Cr Negative Cash Flow 3/10
March 2025 ₹37 Cr ₹27 Cr Positive Free Cash Flow 8/10
March 2024 ₹13 Cr ₹13 Cr Positive Free Cash Flow 8/10
March 2023 ₹54 Cr ₹32 Cr Positive Free Cash Flow 8/10
March 2022 ₹29 Cr ₹25 Cr Positive Free Cash Flow 8/10